ELAN

Elanco Animal Health

25.00

+0.91+3.78%

After Hours: 25.10 +0.10 +0.40%17:08 07/02 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE24.32/24.09

TODAY RANGE23.99-25.03

VOL5.69M

MARKET CAP12.49B

52 WEEK RANGE13.39-27.72

AVG VOL (3M)5.80M

% TURNOVER1.14%

TURNOVER--

P/E (TTM)-49.3681

% RANGE4.28%

EPS(TTM)-0.5064

P/E(FORWARD)500.00

P/B1.921

BVPS13.02

DIVIDEND--

P/S2.635

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP12.32B

SHARES OUTSTANDING499.45M

NEXT EARNINGS08/05-08/10

FREE FLOAT492.83M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

Dow Jones·4d ago
Mosaic Co. Stock Slides 5.6%, Underperforms Peers
TipRanks·5d ago
Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (ACAD), Elanco Animal Health (ELAN) and Bristol-Myers Squibb (BMY)
TipRanks·06/24 13:30
Wall Street Analysts Are Bullish on Top Healthcare Picks
Dow Jones·06/18 14:38
Elanco Animal Health Price Target Raised to $32.00/Share From $31.00 by TD Cowen
Dow Jones·06/18 14:38
Elanco Animal Health Is Maintained at Buy by TD Cowen
TipRanks·06/18 12:03
Elanco price target raised to $32 from $31 at TD Cowen
Seeking Alpha·06/18 11:43
Elanco to launch Elanco Ventures with $25M commitment to back early-stage animal health innovation
TipRanks·06/18 11:30
Elanco to launch Elanco Ventures for animal health innovation
TipRanks·06/18 10:45
Elanco Upgraded to Buy on Blockbuster Product Cycle, Robust Pipeline, and Higher Price Target Outlook
Dow Jones·06/16 20:35
Mosaic Co. Stock Falls 3.7%, Underperforms Peers
NASDAQ·06/15 13:04
Elanco Animal Health Announces USDA Approval Of TruCan Ultra Lyme-L4
TipRanks·06/15 12:50
Elanco announces USDA approval of TruCan Ultra Lyme-L4
PR Newswire·06/15 12:47
Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs
Dow Jones·06/12 20:33
Mosaic Co. Stock Rallies 7.6%, Outperforms Peers
TipRanks·06/11 09:21
Barclays Reaffirms Their Buy Rating on Elanco Animal Health (ELAN)

Same Industry

Name/Symbol

Change%

Price

ELAN

MCK

Biogen Inc

BIIB

+0.28%

216.63

Amgen Inc

AMGN

+1.56%

358.33

Shire

SHPG

0.00%

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

-1.08%

0.1187

LLY

CELG

TXMD

Johnson & Johnson

JNJ

-1.76%

253.97

Abbvie Inc

ABBV

-0.66%

252.63

ZTS

Gilead Sciences Inc

GILD

+3.68%

130.61

Novo-Nordisk A/S

NVO

+3.68%

50.56

Bristol-Myers Squibb Co

BMY

+3.35%

57.68

Alexion Pharms

ALXN

+1.70%

182.50

PFE

Sanofi FR

SNY

+2.75%

42.95

GCVRZ

Novartis

NVS

-1.24%

154.78

Dr Reddys Labs

RDY

-3.45%

13.99

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.